Nurix Therapeutics, Inc. (NRIX)
19.54
-1.93
(-8.99%)
USD |
NASDAQ |
Dec 09, 16:00
19.54
0.00 (0.00%)
After-Hours: 20:00
Nurix Therapeutics Shareholders Equity (Quarterly): 372.25M for Aug. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 21.54B |
| Pfizer Inc. | 92.80B |
| EyePoint Pharmaceuticals, Inc. | 200.18M |
| GT Biopharma, Inc. | 3.00M |
| KalVista Pharmaceuticals, Inc. | 17.00M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 522.47M |
| Total Liabilities (Quarterly) | 150.22M |
| Debt to Equity Ratio | 0.1517 |
| Current Ratio | 5.350 |
| Net Debt Paydown Yield | -0.77% |